These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21917108)

  • 1. Leptin for type 1 diabetes: coming onto stage to be (or not?).
    Oral EA
    Pediatr Diabetes; 2012 Feb; 13(1):68-73. PubMed ID: 21917108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leptin applications in 2015: what have we learned about leptin and obesity?
    Farr OM; Gavrieli A; Mantzoros CS
    Curr Opin Endocrinol Diabetes Obes; 2015 Oct; 22(5):353-9. PubMed ID: 26313897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism.
    Havel PJ
    Diabetes; 2004 Feb; 53 Suppl 1():S143-51. PubMed ID: 14749280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidants protect against diabetes by improving glucose homeostasis in mouse models of inducible insulin resistance and obesity.
    Straub LG; Efthymiou V; Grandl G; Balaz M; Challa TD; Truscello L; Horvath C; Moser C; Rachamin Y; Arnold M; Sun W; Modica S; Wolfrum C
    Diabetologia; 2019 Nov; 62(11):2094-2105. PubMed ID: 31309261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The long road to leptin.
    Friedman J
    J Clin Invest; 2016 Dec; 126(12):4727-4734. PubMed ID: 27906690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 20 years of leptin: leptin at 20: an overview.
    Friedman J
    J Endocrinol; 2014 Oct; 223(1):T1-8. PubMed ID: 25121999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical utility of leptin therapy in metabolic dysfunction.
    Park JY; Gavrilova O; Gorden P
    Minerva Endocrinol; 2006 Jun; 31(2):125-31. PubMed ID: 16682936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical efficacy of the adipocyte-derived hormone leptin in metabolic dysfunction.
    Gorden P; Park JY
    Arch Physiol Biochem; 2006 Apr; 112(2):114-8. PubMed ID: 16931453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 20 years of leptin: human disorders of leptin action.
    Farooqi IS; O'Rahilly S
    J Endocrinol; 2014 Oct; 223(1):T63-70. PubMed ID: 25232148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin.
    Havel PJ
    Curr Opin Lipidol; 2002 Feb; 13(1):51-9. PubMed ID: 11790963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The emerging role of leptin in humans.
    Kelesidis T; Mantzoros CS
    Pediatr Endocrinol Rev; 2006 Mar; 3(3):239-48. PubMed ID: 16639389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leptin activates hepatic 5'-AMP-activated protein kinase through sympathetic nervous system and α1-adrenergic receptor: a potential mechanism for improvement of fatty liver in lipodystrophy by leptin.
    Miyamoto L; Ebihara K; Kusakabe T; Aotani D; Yamamoto-Kataoka S; Sakai T; Aizawa-Abe M; Yamamoto Y; Fujikura J; Hayashi T; Hosoda K; Nakao K
    J Biol Chem; 2012 Nov; 287(48):40441-7. PubMed ID: 23024365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy.
    Petersen KF; Oral EA; Dufour S; Befroy D; Ariyan C; Yu C; Cline GW; DePaoli AM; Taylor SI; Gorden P; Shulman GI
    J Clin Invest; 2002 May; 109(10):1345-50. PubMed ID: 12021250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human obesity and insulin resistance: lessons from experiments of nature.
    O'Rahilly S
    Novartis Found Symp; 2007; 286():13-20; discussion 20-3, 162-3, 196-203. PubMed ID: 18269171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in understanding lipodystrophy: a focus on lipodystrophy-associated cardiovascular disease and potential effects of leptin therapy on cardiovascular function.
    Bruder-Nascimento T; Kress TC; Belin de Chantemele EJ
    F1000Res; 2019; 8():. PubMed ID: 31656583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leptin production capacity determines food intake and susceptibility to obesity-induced diabetes in Oikawa-Nagao Diabetes-Prone and Diabetes-Resistant mice.
    Asai A; Nagao M; Hayakawa K; Miyazawa T; Sugihara H; Oikawa S
    Diabetologia; 2020 Sep; 63(9):1836-1846. PubMed ID: 32561946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metreleptin: first global approval.
    Chou K; Perry CM
    Drugs; 2013 Jun; 73(9):989-97. PubMed ID: 23740412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms of central leptin resistance in obesity.
    Jung CH; Kim MS
    Arch Pharm Res; 2013 Feb; 36(2):201-7. PubMed ID: 23359004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of paradoxical observations on the association between leptin and insulin resistance.
    Ceddia RB; Koistinen HA; Zierath JR; Sweeney G
    FASEB J; 2002 Aug; 16(10):1163-76. PubMed ID: 12153984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An approximation to the temporal order in endogenous circadian rhythms of genes implicated in human adipose tissue metabolism.
    Garaulet M; Ordovás JM; Gómez-Abellán P; Martínez JA; Madrid JA
    J Cell Physiol; 2011 Aug; 226(8):2075-80. PubMed ID: 21520059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.